GLP-1 medications for teens with type 2 diabetes and obesity frequently denied by insurance companies
Health insurance companies often deny coverage for GLP-1 receptor agonists (GLP1Ra) that treat children and teens with obesity and type 2...
top of page
Browse by category
Search
CMS' semaglutide coverage expansion could save millions of lives
A group of 44 health care and advocacy organizations is urging the Centers for Medicare & Medicaid Services (CMS) to expand coverage and...
National Alliance of Healthcare Purchaser Coalitions releases employer recommendations to address obesity coverage
For over 30 years, the National Alliance of Healthcare Purchaser Coalitions (National Alliance) has united business healthcare coalitions...
ECRI report identifies reasons weight loss drugs have been underutilised
ECRI, the largest non-profit patient safety organisation in the US, is calling on healthcare leaders to change their approach and fully...
Browse by tag
bottom of page